Biotech / Medical : ARAY Accuray Cyberknife Robotic RadioSurgery


 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
From: Savant4/9/2012 10:17:41 AM
of 70
 
Accuray Incorporated to Report Financial Results for Third Quarter of Fiscal 2012

SUNNYVALE, Calif., April 9, 2012 /PRNewswire via COMTEX/ -- Accuray Incorporated
(ARAY), the premier radiation oncology company, today announced that it will
report results for its third quarter of fiscal year 2012, ended March 31, 2012 on
Tuesday, May 8, 2012 after the market closes.

A conference call to review the results of its third quarter of fiscal year 2012
will begin at 2:00 p.m. PDT/5:00 p.m. EDT and will be hosted by Euan S. Thomson,
Ph.D., president and chief executive officer and Derek Bertocci, senior vice
president and chief financial officer.

The conference call dial-in numbers are 1-866-203-3206 (USA) or 1-617-213-8848
(International), Conference ID: 41410037. In addition, a dial-up replay of the
conference call will be available beginning May 8, 2012 at 5:00 p.m. PDT/8:00
p.m. EDT and ending on May 14, 2012. The replay telephone number is
1-888-286-8010 (USA) or 1-617-801-6888 (International), Conference ID: 59135049.

A live webcast of the call will also be available from the Investor Relations
section of the corporate website at accuray.com  A webcast
replay can be accessed on the corporate website beginning Tuesday, May 8, 2012 at
approximately 5:00 p.m. PDT/8:00 p.m. EDT. The replay will remain available until
Accuray announces its results for the fourth quarter of fiscal 2012, ending June
30, 2012.

About AccurayAccuray Incorporated (ARAY), based in Sunnyvale, Calif., is the
premier radiation oncology company that develops, manufactures and sells
personalized innovative treatment solutions that set the standard of care, with
the aim of helping patients live longer, better lives. The Company's leading edge
technologies - the CyberKnife and TomoTherapy Systems - are designed to deliver
radiosurgery, stereotactic body radiation therapy, intensity modulated radiation
therapy, image guided radiation therapy, and adaptive radiation therapy. To date,
more than 300,000 patients worldwide have been treated using the Company's
technologies and more than 616 systems have been installed in leading hospitals
around the world. For more information, please visit accuray.com. 
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

Copyright © 1995-2013 Knight Sac Media. All rights reserved.